Proton pump inhibitors are overused. Deprescribing should be considered after appropriate duration. – http://www.tiefenpsychologisch-fundierte-psychotherapie.de/Links_A/links_a.html , Strong evidence presented for GLP-1 agonists in obesity treatment. Their metabolic benefits extend far beyond weight loss. .